Drug intelligence / Profile preview

IHJ-301

Development stage
Preclinical
Lead developer
iHeart Japan
Modality
Hydrogel Systems → Drug Delivery Systems, iPSCs → Pluripotent Stem Cells → Stem Cell Therapies → Cell Therapies
Administration
Epicardial
01

Overview

IHJ-301 is an induced pluripotent stem cell (iPSC)-derived regenerative medicine product developed by iHeart Japan for the treatment of severe heart failure, including dilated cardiomyopathy and ischemic heart disease. The therapy consists of multi-layered cardiovascular cell sheets manufactured using a proprietary gelatin hydrogel microsphere technology originally developed at Kyoto University. IHJ-301 functions primarily through a paracrine mechanism, where the transplanted cells secrete a variety of cytokines and extracellular vesicles that promote tissue repair and improve cardiac function. Preclinical studies in porcine myocardial infarction models have demonstrated significant recovery of cardiac function, with levels reaching those of healthy subjects.

Other names
cardiovascular cell multilayer productmulti-layered cardiac cell sheets再生医療製品

Beyond the preview

Go deeper on IHJ-301.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on IHJ-301.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call